Dario Demonstrates Clinically Meaningful Blood Glucose Improvements and Personalized Glycemic Trajectories Across 22,000+ Users: Machine Learning Study Findings Published in Frontiers in Digital Health

Stock Information for Cryo-Cell International, Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Cryo-Cell International, Inc.

DarioHealth Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
DarioHealth to Report Fourth Quarter and Full Year 2025 Results on Thursday, March 19, 2026
Dario Uniquely Positioned to Amplify the Impact of Oral GLP-1 Therapies Through Precision Behavioral Support: 79% of Members Already Using Dario's Weight Management
Dario Surpasses 100 Scientific Studies, Cementing Leadership Among Digital Health's Most Evidence-Based Platforms
Dario Launches DarioIQ(TM) AI Integration in Dario Health App with Direct-to-Consumer First Version for Hypertension Members
Dario's Data-Driven Digital Health Platform Delivers Significant and Sustainable Improvements in Blood Pressure: Findings Published in JMIR Cardio
DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date
DarioHealth Announces Publication of Sanofi Study in JMIR Demonstrating an Estimated $5,077 Medical Cost Savings Per Dario Digital Health Platform User Per Year

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.